Abilify And Six New Drugs Push Otsuka’s 2012 Results Up 7.8%
This article was originally published in PharmAsia News
Executive Summary
Otsuka Holdings announced 2012 Japan sales results of ¥351.8 billion ($3.4 billion), a 7.8% increase from the previous year.